TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06248476

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial magnetic stimulation is non-invasive stimulation technique which modifies cortical excitability through forming magnetic field

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial magnetic stimulation is non-invasive stimulation technique which modifies cortical excitability through forming magnetic field
Study: NCT06674018

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Indole-3-propionic acid
Description: A dosis of either 50 mg IPA, 120 mg IPA or 500 mg IPA (two capsules) will be taken orally, once daily in the morning after an overnight fast for 14 consecutive days.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two capsules of placebo will be taken orally, once daily in the morning after an overnight fast for 14 consecutive days.
Study: NCT05353985

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-062
Description: TAK-062 tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-062
Description: TAK-062 tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-062
Description: TAK-062 tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-062
Description: TAK-062 tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-062
Description: TAK-062 tablets.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar
Description: SIGE gluten bars.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar
Description: SIGE gluten bars.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar
Description: SIGE gluten bars.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar
Description: SIGE gluten bars.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-Bar
Description: SIGE gluten bars.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TAK-062 Placebo
Description: TAK-062 placebo-matching tablets.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TAK-062 Placebo
Description: TAK-062 placebo-matching tablets.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TAK-062 Placebo
Description: TAK-062 placebo-matching tablets.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar
Description: SIGE gluten-free bars.
Study: NCT06248476

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial magnetic stimulation is non-invasive stimulation technique which modifies cortical excitability through forming magnetic field
Study: NCT05353985

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar
Description: SIGE gluten-free bars.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Simulated Inadvertent Gluten Exposure (SIGE) Gluten-free Bar
Description: SIGE gluten-free bars.
Study: NCT06619561

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vimseltinib
Description: Administered orally
Study: NCT06617832

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active drug for acute migraine treatment
Description: Standard dose of Sumatriptan 100 mg, which is used as an acute treatment for episodic migraine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Inactive placebo pill (100 mg) looking like the active drug
Study: NCT06624449

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cold debriefing
Description: Manipulation (experimental): The researcher assigned a cold debriefing (after one-day post-simulation) for undergraduate nursing students in the intervention group.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Hot Debriefing
Description: The control group received a hot debriefing (immediately after the simulation).
Study: NCT06683222

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Blood sample
Description: 36 ml of blood in 3 x 7 ml dry tubes, 1 x 5 ml EDTA tube, 1 x 5 ml heparinized tube, 1 x 5 ml anti-protease tube)

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Saliva sample
Description: 5 ml of saliva will be taken.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Grip test
Description: The grip strength of the dominant arm will be measured with the participant in a standing position, with the arm close to the body and the elbow at 90◦ flexion, while the non-dominant arm will be positioned alongside the body. Three measurements will be taken for the dominant hand, and the mean value will be calculated and used for analysis. One minute is allowed between each repetition, to avoid muscle fatigue. Dynamometer quality control is ensured by regularly checking known resistance values.
Study: NCT06424119

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Cardiac Rehabilitation
Description: Patient must have a qualifying cardiovascular event and eligible for ICR. Once patient is randomized to TCR arm, they will attend 36 sessions of the program at one of three locations.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive Cardiac Rehabilitation
Description: Patient must have a qualifying cardiovascular event and eligible for ICR. Once patient is randomized to ICR arm, they will attend 72 sessions of the program at one of three locations.
Study: NCT06683222

Intervention type: OTHER
Group type: OTHER
Intervention: MicroFET2® maximum isometric force test
Description: The microFET2 device is used to test isometric force. The microFET2 dynamometer is battery-powered and ergonomically designed to fit in the palm of the hand. The system is microprocessor-controlled to provide accurate, repeatable muscle force readings. The microFET Clinical software automatically performs calculations and validity tests, and allows graphs to be generated from the data, enabling reports of different patient tests to be compared

Intervention type: OTHER
Group type: OTHER
Intervention: Maximum isometric knee extension bench test.
Description: The maximal isometric knee extension strength test on a specially-adapted strength bench consists in performing 3 maximal contractions with 1 minute's rest between each test.

Intervention type: OTHER
Group type: OTHER
Intervention: The SPPB (Short Physical Performance Battery)
Description: Battery of tests comprising a balance test, a walking speed test and a chair-lift test

Intervention type: OTHER
Group type: OTHER
Intervention: The 6-minute walking test.
Description: Muscular function will be determined by the 6-minute walk test to assess aerobic endurance. Participants will be asked to walk for 6 min as fast as possible on a shuttle track. The distance (m) covered in 6 min will be measured. Walking speed (m/s) will be calculated as the distance (m) covered in 6 min. A walking speed \<0.8 m/s has been defined as a low value.

Intervention type: OTHER
Group type: OTHER
Intervention: Segmental impedancemetry examination.
Description: Segmental impedancemetry involves measuring body composition using the body's resistance to the passage of a low-intensity electric current. This test is harmless to the body.

Intervention type: OTHER
Group type: OTHER
Intervention: Indirect calorimetry test.
Description: An Indirect calorimetry is the standard method for measuring energy expenditure at rest. It is based on the principle that the human body burns nutrients using O2 and producing CO2.

Intervention type: OTHER
Group type: OTHER
Intervention: Fardellone's questionnaire
Description: Completion of a questionnaires on calcium intake (Fardellone)
Study: NCT06424119

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive Cardiac Rehabilitation
Description: Patient must have a qualifying cardiovascular event and eligible for ICR. Once patient is randomized to ICR arm, they will attend 72 sessions of the program at one of three locations.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: C2life® Food
Description: Patient must have a qualifying cardiovascular event and eligible for ICR. Once patient is randomized to ICR arm with food, they will receive the food at the beginning of the second week of their respective program. Food will be delivered by mail weekly for a total of 11 weeks to the patient's home address.
Study: NCT06683222

Intervention type: OTHER
Group type: OTHER
Intervention: ONAPS questionnaire
Description: The ONAPS questionnaire contains questions on physical activity and sedentariness

Intervention type: OTHER
Group type: OTHER
Intervention: Dietary intake.questionnaire
Description: The dietary intake questionnaire contains questions regarding the person's eating habits - how many meals a day, where they eat, whether they eat alone, what foods they eat/drink and whether they are following a particular diet and, if so, the reasons why.
Study: NCT06688851

Intervention type: DIAGNOSTIC_TEST
Intervention: Preoperative Cone Beam Computed Tomography (CBCT) scan
Description: A CBCT scan is performed before the surgical intervention.

Intervention type: PROCEDURE
Intervention: Cystostomy
Description: Under local anesthesia, a full-thickness flap is prepared and cystostomy is performed.

Intervention type: DIAGNOSTIC_TEST
Intervention: Histology to confirm the initial diagnosis
Description: A sample of the cyst lining is sent for histologic diagnosis.

Intervention type: DEVICE
Intervention: Patient Specific Implant
Description: The PSI is fixed on the surface of the bone using osteosynthesis screws.
Study: NCT05030389

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activity (APA)
Description: The APA program lasts 12 weeks and consists in three one-hour at-home sessions a week (total of 36 sessions), including two aerobic dominant web-based sessions and one muscle strengthening self-guided session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activity (APA)
Description: The APA program lasts 12 weeks and consists in three one-hour at-home sessions a week (total of 36 sessions), including two aerobic dominant web-based sessions and one muscle strengthening self-guided session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bright Light Exposure (BLE)
Description: Bright light exposure (BLE) consists in using lamps for light therapy during 12 weeks, at the rate of five one-hour at-home sessions a week.
Study: NCT06688851

Intervention type: PROCEDURE
Intervention: Cyst decompression
Description: The PSI enables the discharge of the cystic liquid into the oral cavity. The resulting decrease in cystic pressure induces bone healing. Patients are recalled monthly for controls and panoramic X-rays are performed to monitor the decompression.

Intervention type: DIAGNOSTIC_TEST
Intervention: CBCT
Description: Post-operative CBCT is performed six months after cystostomy to assess whether the cyst volume has been sufficiently reduced for enucleation, minimizing the risk of damage to anatomical landmarks.

Intervention type: PROCEDURE
Intervention: Enucleation
Description: Under local anesthesia a full-thickness flap is raised and the PSI is removed by unscrewing the osteosynthesis screws. The wall of the cyst is completely enucleated and the flap is sutured.

Intervention type: DIAGNOSTIC_TEST
Intervention: Histology performed on the entire lining of the cyst
Description: The residual cyst wall is sent for histopathologic examination.
Study: NCT05807763

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic paraesophageal hernia repair without fundoplication
Description: Patients undergoing laparoscopic paraesophageal hernia repair will be evaluated for risk of esophageal reflux using intra-operative impedance planimetry and endoscopic gastroesophageal valve grade. Patients deemed low risk for esophageal reflux will then be randomized to partial fundoplication or no fundoplication.
Study: NCT05030389

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Galvanic Vestibular Stimulation (GVS)
Description: The GVS program lasts 2 weeks and consists in five 20-minutes at-home sessions a week (total of 10 sessions), using a portable galvanic stimulator.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education program (HE)
Description: The HE program lasts 14 weeks and consists in one one-hour at-home session a week (total of 14 sessions). This web-based intervention includes courses on general health (sleep habits, diet, physical activity, cardiovascular diseases, etc.).
Study: NCT06626711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Propofol as a part of total venous anesthesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: Sevoflurane as a part of intravenous anesthesia
Study: NCT06701318

Intervention type: DEVICE
Intervention: Ultrasound shear wave elastography
Description: An ultrasound machine (GE LogiQ S8) equipped with SWE technology will be used. A high-frequency linear transducer will be used and The machine settings will be optimized for musculoskeletal applications.

Intervention type: DEVICE
Intervention: Ultrasound shear wave elastography
Description: An ultrasound machine (GE LogiQ S8) equipped with SWE technology will be used. A high-frequency linear transducer will be used and The machine settings will be optimized for musculoskeletal applications.
Study: NCT06698601

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: blueberry-rich diet
Description: The study participants follow a diet rich in blueberries for 12 weeks based on the nutritional therapy and the integrative medical concept taught during their inpatient stay at the clinic for internal and integrative medicine in Bamberg.~Participants will drink approximately 35g of a powder made from wild, freeze-dried blueberries containing 780mg of anthocyanines stirred in a glas of water every morning for a period of 12 weeks.

Intervention type: OTHER
Group type: OTHER
Intervention: Control diet
Description: The study participants will focus on the nutritional therapy and the integrative medical concept taught during their inpatient stay at the clinic for internal and integrative medicine in Bamberg.~Participants will receive no additional blueberry treatment.
Study: NCT06703281

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Interscalene Nerve Block
Description: Patients assigned to the Interscalene Nerve Block would have spirometry and ultrasound-guided diaphragm excursion measurements both pre and post-blok 30 minutes.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Superior trunk block
Description: Patients assigned to the Superior Trunk Nerve Block would have spirometry and ultrasound-guided diaphragm excursion measurements both pre and post-blok 30 minutes.
Study: NCT06708221

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real-Time Image Guided Radio Therapy (IGRT)
Description: Real-time image guided radiation therapy (IGRT) methods image the cancerous tumour in real-time, enabling the treatment beam to focus its destructive energy on the patient's cancer, not their healthy tissue.
Study: NCT06710691

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity intervention using traditional strength training protocols
Description: Strength training participants performed the 6 reps of the first exercise at the prescribed RPE and then rested for 1 minute. Participants then completed another set of their first exercise with the required rest until the prescribed sets were completed. Participants performed the second and third exercises in the same fashion. Once the first block was completed, participants rested 5 min, then completed the second block. Six exercises were completed.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity intervention using traditional strength training protocols
Description: Strength training participants performed the 6 reps of the first exercise at the prescribed RPE and then rested for 1 minute. Participants then completed another set of their first exercise with the required rest until the prescribed sets were completed. Participants performed the second and third exercises in the same fashion. Once the first block was completed, participants rested 5 min, then completed the second block. Six exercises were completed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity intervention using high-resistance circuit training.
Description: An adapted version of Alcaraz's high-resistance circuit training (HRC) was utilized in the intervention. Exercises and intensities used by strength training was the same for HRC except HRC participants performed the first three exercises as a circuit with 35 seconds rest between exercises, then completed the second block of exercises in the same fashion.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity intervention using high-resistance circuit training.
Description: An adapted version of Alcaraz's high-resistance circuit training (HRC) was utilized in the intervention. Exercises and intensities used by strength training was the same for HRC except HRC participants performed the first three exercises as a circuit with 35 seconds rest between exercises, then completed the second block of exercises in the same fashion.
Study: NCT06709131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAR-T cells（ chimeric antigen receptor T cells）
Description: CAR-T cells（ chimeric antigen receptor T cells）
Study: NCT06710119

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Visual Feedback
Description: Visual feedback of foot loading during gait.
Study: NCT06707649

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Management Education
Description: Patients in this group will receive self-management education during the 3 days when they are in the hospital. On the first day of the training, COPD disease, causes of the disease, symptoms, reasons for alleviating complaints, practical information for living comfortably with COPD will be given. On the second day, emergency situations in COPD, what is an exacerbation and prevention suggestions and diaphragmatic breathing-cough exercises will be taught. On the last day, training will be given on pursed lip breathing, medication use, oxygen and nebulizer treatments. The education will be accompanied by a educational booklet prepared by researchers and expert opinion.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Management Education
Description: Patients in this group will receive self-management education during the 3 days when they are in the hospital. On the first day of the training, COPD disease, causes of the disease, symptoms, reasons for alleviating complaints, practical information for living comfortably with COPD will be given. On the second day, emergency situations in COPD, what is an exacerbation and prevention suggestions and diaphragmatic breathing-cough exercises will be taught. On the last day, training will be given on pursed lip breathing, medication use, oxygen and nebulizer treatments. The education will be accompanied by a educational booklet prepared by researchers and expert opinion.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self Management Education
Description: Patients in this group will receive self-management education during the 3 days when they are in the hospital. On the first day of the training, COPD disease, causes of the disease, symptoms, reasons for alleviating complaints, practical information for living comfortably with COPD will be given. On the second day, emergency situations in COPD, what is an exacerbation and prevention suggestions and diaphragmatic breathing-cough exercises will be taught. On the last day, training will be given on pursed lip breathing, medication use, oxygen and nebulizer treatments. The education will be accompanied by a educational booklet prepared by researchers and expert opinion.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone Follow-up
Description: Patients will receive their first call one week after discharge. The calls will be scheduled weekly during the first month, biweekly in the second month, and monthly starting from the third month. During the calls, it is planned to repeat the educational content and answer the patient's questions.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telephone Follow-up
Description: Patients will receive their first call one week after discharge. The calls will be scheduled weekly during the first month, biweekly in the second month, and monthly starting from the third month. During the calls, it is planned to repeat the educational content and answer the patient's questions.
Study: NCT06710132

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M9140
Description: All participants will receive 2.8 milligram per kilogram (mg/kg) M9140 intravenously (i.v.) every 3 weeks (q3w) on Day 1 of consecutive 21-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M9140
Description: All participants will receive 2.8 milligram per kilogram (mg/kg) M9140 intravenously (i.v.) every 3 weeks (q3w) on Day 1 of consecutive 21-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M9140
Description: All participants will receive 2.8 milligram per kilogram (mg/kg) M9140 intravenously (i.v.) every 3 weeks (q3w) on Day 1 of consecutive 21-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M9140
Description: All participants will receive 2.8 milligram per kilogram (mg/kg) M9140 intravenously (i.v.) every 3 weeks (q3w) on Day 1 of consecutive 21-day cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M9140
Description: All participants will receive 2.8 milligram per kilogram (mg/kg) M9140 intravenously (i.v.) every 3 weeks (q3w) on Day 1 of consecutive 21-day cycles.
Study: NCT06706778

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music intervention
Description: Based on the NIH toolkit and MBIs reporting guidelines, the engagement in this pilot study will be receptive by providing participants with prerecorded, preselected playlists. Participants will also receive a guided video on maximizing music's therapeutic benefits. The playlists will be purely instrumental, with a 60-80 bpm tempo, and feature melodies and harmonies designed for stress relief, including soothing, grounding, meditation, emotional release, etc. This approach is resource-efficient and easily accessible, allowing participants to integrate it into daily pain self-management strategies. Participants will be asked to engage in the MBI in the morning and at night for 30 minutes each, wearing the abdominal belt and smartwatch.
Study: NCT06707428

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: compression stockings
Description: compression stockings used during cesarean section